Impact Factor Collection
The European Journal of Endocrinology's 2019 Impact Factor has risen to its highest ever ranking of 5.308, with the five-year measure also increasing to 5.077.
To celebrate the European Journal of Endocrinology's new Impact Factor, the journal Editorial Team have compiled a collection of highly cited articles contributing to the latest Impact Factor.
Highly cited in 2019
European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors
Martin Fassnacht et al.
GENETICS IN ENDOCRINOLOGY: Genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing
Luigi Maione et al.
MANAGEMENT OF ENDOCRINE DISEASE: Novel anabolic treatments for osteoporosis
Ernesto Canalis et al.
THERAPY OF ENDOCRINE DISEASE: Denosumab vs bisphosphonates for the treatment of postmenopausal osteoporosis
Athanasios D Anastasilakis, Stergios A Polyzos and Polyzois Makras
DIAGNOSIS OF ENDOCRINE DISEASE: Bone turnover markers: are they clinically useful?
Richard Eastell et al.
MANAGEMENT OF ENDOCRINE DISEASE: Diagnosis and management of primary aldosteronism: the Endocrine Society guideline 2016 revisited
Tracy Ann Williams and Martin Reincke
GENETICS IN ENDOCRINOLOGY: Approaches to molecular genetic diagnosis in the management of differences/disorders of sex development (DSD): position paper of EU COST Action BM 1303 ‘DSDnet’
L Audí et al.
MANAGEMENT OF ENDOCRINE DISEASE: Personalized medicine in the treatment of acromegaly
Leandro Kasuki, Luiz Eduardo Wildemberg and Mônica R Gadelha
Identifying and treating subclinical thyroid dysfunction in pregnancy: emerging controversies
Inés Velasco and Peter Taylor